JP6424091B2 - 妊孕能または生殖機能を向上させるか、改善するか、または増大させるための方法 - Google Patents

妊孕能または生殖機能を向上させるか、改善するか、または増大させるための方法 Download PDF

Info

Publication number
JP6424091B2
JP6424091B2 JP2014561103A JP2014561103A JP6424091B2 JP 6424091 B2 JP6424091 B2 JP 6424091B2 JP 2014561103 A JP2014561103 A JP 2014561103A JP 2014561103 A JP2014561103 A JP 2014561103A JP 6424091 B2 JP6424091 B2 JP 6424091B2
Authority
JP
Japan
Prior art keywords
supplement
fatty acids
dha
omega
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014561103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510760A5 (enExample
JP2015510760A (ja
Inventor
マーク ピューダー
マーク ピューダー
ディーピカ ネーラ
ディーピカ ネーラ
ボー アール． ルエダ
ボー アール． ルエダ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of JP2015510760A publication Critical patent/JP2015510760A/ja
Publication of JP2015510760A5 publication Critical patent/JP2015510760A5/ja
Application granted granted Critical
Publication of JP6424091B2 publication Critical patent/JP6424091B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2014561103A 2012-03-07 2013-03-07 妊孕能または生殖機能を向上させるか、改善するか、または増大させるための方法 Active JP6424091B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261607884P 2012-03-07 2012-03-07
US61/607,884 2012-03-07
US201261695510P 2012-08-31 2012-08-31
US61/695,510 2012-08-31
PCT/US2013/029553 WO2013134482A1 (en) 2012-03-07 2013-03-07 Methods for enhancing, improving, or increasing fertility or reproductive function

Publications (3)

Publication Number Publication Date
JP2015510760A JP2015510760A (ja) 2015-04-13
JP2015510760A5 JP2015510760A5 (enExample) 2016-04-21
JP6424091B2 true JP6424091B2 (ja) 2018-11-14

Family

ID=47892067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014561103A Active JP6424091B2 (ja) 2012-03-07 2013-03-07 妊孕能または生殖機能を向上させるか、改善するか、または増大させるための方法

Country Status (6)

Country Link
US (1) US9295662B2 (enExample)
EP (1) EP2822403B1 (enExample)
JP (1) JP6424091B2 (enExample)
AU (1) AU2013230896B2 (enExample)
CA (1) CA2866606C (enExample)
WO (1) WO2013134482A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6284768B2 (ja) * 2014-01-16 2018-02-28 株式会社紀州ほそ川 不妊治療剤
US10004711B2 (en) * 2014-05-08 2018-06-26 Dsm Ip Assets B.V. Methods and compositions comprising 10-hydroxy-2-decenoic acid
BR112017002553A2 (pt) * 2014-09-30 2017-12-05 Nestec Sa composição nutricional a ser usada para tratar ou prevenir condições relacionadas à gravidez
JP6788381B2 (ja) * 2016-05-30 2020-11-25 岩手県 酸化ストレス抑制剤
GR1009657B (el) * 2016-11-07 2019-11-28 Βαρβαρα Γεωργιου Γελαδακη Συνθεσεις για χορηγηση απο το στομα με ανοσοτροποποιητικη δραση στα φυσικα φονικα κυτταρα
WO2025231097A1 (en) * 2024-05-02 2025-11-06 Cold Spring Harbor Laboratory Use of arachidonic acid for promoting endometrial epithelium regeneration and stem cell plasticity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
IL125097A (en) 1998-06-25 2003-01-12 Israel State Dietary manipulation to increase fertility
US6576253B2 (en) * 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
US20030060509A1 (en) * 2001-08-24 2003-03-27 Elswyk Mary Van Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US6576667B2 (en) * 2001-11-14 2003-06-10 Norel Acquisition Corp. Method for manufacturing fatty acid calcium salts from high glyceride content oils
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
US8263137B2 (en) * 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8652508B2 (en) 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders

Also Published As

Publication number Publication date
US9295662B2 (en) 2016-03-29
WO2013134482A1 (en) 2013-09-12
EP2822403A1 (en) 2015-01-14
AU2013230896A1 (en) 2014-09-25
JP2015510760A (ja) 2015-04-13
CA2866606C (en) 2022-03-15
CA2866606A1 (en) 2013-09-12
EP2822403B1 (en) 2022-05-04
US20150025048A1 (en) 2015-01-22
AU2013230896B2 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
Nehra et al. Prolonging the female reproductive lifespan and improving egg quality with dietary omega‐3 fatty acids
JP6424091B2 (ja) 妊孕能または生殖機能を向上させるか、改善するか、または増大させるための方法
Moallem et al. Dietary α-linolenic acid from flaxseed oil or eicosapentaenoic and docosahexaenoic acids from fish oil differentially alter fatty acid composition and characteristics of fresh and frozen-thawed bull semen
Uauy et al. Nutrition in brain development and aging: role of essential fatty acids
Kimura et al. Long-term supplementation of docosahexaenoic acid-rich, eicosapentaenoic acid-free microalgal oil in n-3 fatty acid-deficient rat pups
McGregor et al. The omega-3 story:: Nutritional prevention of preterm birth and other adverse pregnancy outcomes
US20100048705A1 (en) Methods of treating and preventing neovascularization with omega-3 polyunsaturated fatty acids
Leaf et al. Factors affecting long‐chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants
TWI749451B (zh) 包含ω脂肪酸的醫藥組合物及包含彼之輸液製劑
CN101437508A (zh) 用于改善心血管健康的十八碳四烯酸
CN112384203A (zh) 用于胃肠外施用的脂质乳剂
Ohtsuka et al. ω-3 fatty acids attenuate mucosal inflammation in premature rat pups
Gázquez et al. DHA supplementation during pregnancy as phospholipids or TAG produces different placental uptake but similar fetal brain accretion in neonatal piglets
Donda et al. Human milk lipids induce important metabolic and epigenetic changes in Neonates
WO1999066877A2 (en) Dietary manipulation to increase fertility
Bianconi et al. Effects of dietary omega-3 PUFAs on growth and development: Somatic, neurobiological and reproductive functions in a murine model
Bettger et al. Nervonic acid is transferred from the maternal diet to milk and tissues of suckling rat pups
Hess et al. Enrichment of intestinal mucosal phospholipids with arachidonic and eicosapentaenoic acids fed to suckling piglets is dose and time dependent
Xiang et al. Relation between polyunsaturated fatty acids and growth
CN105899204A (zh) 膳食dha-磷脂用于新生儿大脑dha和dpa积累的功效
Lifshitz et al. Sub-chronic (13-week) oral toxicity study, preceded by an in utero exposure phase and genotoxicity studies with fish source phosphatidylserine in rats
Langerhuus et al. Effects of dietary n-3 and n-6 fatty acids on clinical outcome in a porcine model on post-operative infection
Kassem et al. Dietary (n-6: n-3) fatty acids alter plasma and tissue fatty acid composition in pregnant Sprague Dawley rats
Kimura et al. Supplementation of DHA‐rich microalgal oil or fish oil during the suckling period in mildly n‐3 fatty acid‐deficient rat pups
van Goor et al. Maternal and fetal brain contents of docosahexaenoic acid (DHA) and arachidonic acid (AA) at various essential fatty acid (EFA), DHA and AA dietary intakes during pregnancy in mice

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160301

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20161227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170418

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180625

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180926

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181022

R150 Certificate of patent or registration of utility model

Ref document number: 6424091

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250